Albireo Pharma Inc (ALBO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2010 | 12-2009 | 09-2009 | 06-2009 | 03-2009 | |
| Operating Expenses | 10,391 | 0 | 0 | 10,683 | 11,796 |
| Operating Income | -10,391 | N/A | N/A | -10,683 | -11,796 |
| Other Income | 2 | -11,166 | 0 | 54 | 78 |
| Pre-tax Income | -10,389 | -11,166 | 0 | -10,629 | -11,718 |
| Income Tax | 20 | -18 | N/A | 519 | -89 |
| Net Income Continuous | -10,409 | N/A | N/A | -11,148 | -11,629 |
| Net Income | $-10,409 | $N/A | $N/A | $-11,148 | $-11,629 |
| EPS Basic Total Ops | -52.85 | -56.46 | N/A | -56.46 | -58.86 |
| EPS Basic Continuous Ops | -52.35 | N/A | N/A | -56.36 | -58.90 |
| EPS Diluted Total Ops | -52.85 | -56.46 | N/A | -56.46 | -58.86 |
| EPS Diluted Continuous Ops | -52.35 | N/A | N/A | -56.36 | -58.90 |
| EBITDA(a) | $-9,904 | $N/A | $N/A | $-10,460 | $-11,376 |